Globally, 296 million people are infected with hepatitis B virus (HBV), and approximately one
million people die annually from HBV-related causes, including liver cancer. Although there …

Currently, despite the use of a preventive vaccine for several decades as well as the use of
effective and well-tolerated viral suppressive medications since 1998, approximately 250 …

HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …

There is increasing interest in using dried blood spot (DBS) cards to extend the reach of
global health and disease surveillance programs to hard-to-reach populations …

Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …

Tests to detect the presence and activity of hepatitis B virus (HBV) are the cornerstones of
diagnosis and management. Assays that detect or measure serum levels of HB surface …

Blood collected and dried on a paper card–dried blood spot (DBS)–knows a growing
interest as a sampling method that can be performed outside care facilities by capillary …

Future directions and innovations in hepatitis testing include strategies to improve access
such as through use of existing facility and community-based testing opportunities for …

Background Finger-stick point-of-care and dried blood spot (DBS) hepatitis C virus (HCV)
RNA testing increases testing uptake and linkage to care. This systematic review evaluated …

A large burden of undiagnosed hepatitis virus cases remains globally. Despite the 257
million people living with chronic hepatitis B virus infection, and 71 million with chronic …